Trial Profile
Safety and efficacy on TAS-102 monotherapy in patients with metastatic colorectal cancer according to previous regorafenib
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 22 Jan 2016
Price :
$35
*
At a glance
- Drugs Tipiracil/trifluridine (Primary)
- Indications Colorectal cancer
- Focus Adverse reactions; Therapeutic Use
- 22 Jan 2016 New trial record